General
Preferred name
PRAZIQUANTEL
Synonyms
Praziquantel D11 ()
Droncit ()
Biltricide ()
Pyquiton ()
Praziquantel (Biltricide) ()
2-(CYCLOHEXYLCARBONYL)-1,2,3,6,7,11B-HEXAHYDRO-4H-PYRAZINO(2,1-A)ISOQUINOLIN-4-ONE ()
Praziquantel-d11 ()
Cisticid ()
Praziquantelum ()
NSC-757285 ()
EMBAY 8440 ()
Cestocur ()
EMBAY-8440 ()
Cysticide ()
Cesol ()
P&D ID
PD001793
CAS
55268-74-1
57452-31-0
135526-78-2
1246343-36-1
Tags
natural product
drug
available
Approved by
FDA
First approval
1982
Drug indication
Flatworm infection
Anthelmintic (veterinary)
Drug Status
investigational
vet_approved
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Ca2+ Ionophore; anthelmintic
(LOPAC library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
4
Compound Sets
25
AdooQ Bioactive Compound Library
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
LOPAC library
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Pathogen Box
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
50
Properties
(calculated by RDKit )
Molecular Weight
312.18
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
0
Rotatable Bonds
1
Ring Count
4
Aromatic Ring Count
1
cLogP
2.53
TPSA
40.62
Fraction CSP3
0.58
Chiral centers
1.0
Largest ring
6.0
QED
0.8
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
Unknown molecular target
Selectivity
Ca2+ Ionophore
Target
Parasite
Voltage-activated calcium channel beta 1 subunit
Voltage-activated calcium channel beta 2 subunit
Calcium Channel
antibiotic
COVID-19,Parasite
Disease
REFERENCE COMPOUNDS
Pathway
Anti-infection
Membrane Transporter/Ion Channel
Therapeutic Class
Anthelmintics
Source data